In the present study we investigated whether the BTMs sclerostin, OPG, OPN, OC and DKK-1 could be useful as biomarkers to predict increased risk of new fractures, new cardiovascular events or mortality in a cohort of elderly patients with fractures, stroke and volunteers. This evidence concerns the gene BGLAP and stroke disorder.